Holistic, integrative, functional, precision—the labels are everywhere, but few patients or clinicians know where one ends and the next begins.

The discussion examines the evidence behind common concerns about everyday products, food trends, and lifestyle habits.

A panel of clinical pharmacists meets to discuss the complex process of operationalizing cell and gene therapy at an academic medical center.

Forrest N. Ridgway, PharmD, BCOP, discusses health misinformation, AI-generated medical advice, wellness culture, and the controversial therapies patients are bringing into the clinic.

Jordan Hill, PharmD, BCOP, talks about the impact of the updated NCCN guidelines for triple negative breast cancer.

Experts discuss radon—the second leading cause of lung cancer.

Explore the impact of the Inflation Reduction Act on community oncology practices and discover how new legislation aims to protect patient access to care.

Pharmacists share key insights about the use of ADCs for treatment of breast cancer.

Colorectal cancer cases are on the rise—here is everything you need to know as an oncology pharmacist.

Expert weighs in on data from the AQUILA trial and Johnson & Johnson's approval request for daratumumab for smoldering multiple myeloma.

Pharmacy Times attended the 2024 San Antonio Breast Cancer Symposium from December 10 to December 13.

Expert discussed benefits of precision oncology treatments that utilize thousands of biomarkers to design personalized treatment plans.

Expert discussed the potential of pelareorep, a novel immunotherapeutic agent, in treating advanced or metastatic breast cancer.

Thomas Chen, MD, PhD discussed his innovative approach to brain cancer treatment through NeOnc, Inc.

Expert shares reasons why many women are behind on their annual breast cancer screenings, along with the latest cutting edge treatments in the breast cancer space.

Jennifer Dunphy, DrPH, MBA, MPH and Nelly Awkar-Lazo, MD, discuss the rise in young-onset cancer, the gut-colon cancer link, and the importance of healthy lifestyle choices for cancer prevention.

The PALOMA-3 trial showed subcutaneous amivantamab was better than IV among lung cancer patients.

Pharmacists from Mayo Clinic recap some of the latest treatment opportunities to advance patient care in the oncology space.

The podcast discusses how City of Hope Chicago fully integrates oncology pharmacists into care teams by positioning them in clinics, improving communication and collaboration to minimize delays for patients and enhance care delivery.

A brief overview of 4 recent developments in the treatment of non-small cell lung cancer.

The updated version of the Oncology Care Model (OCM) incentivizes value-based care over volume, but some wonder if it is enough.

This month, we spoke with Cassia Griswold, PharmD, a clinical oncology pharmacist at Mayo Clinic Arizona.

This month, we have a special crossover episode between Pharmacy Focus: Oncology Edition and the Psychedelic Pharmacy podcast.

This month, we spoke with Danielle Roman, PharmD, an oncology clinical pharmacy specialist with Allegheny Health Network.

Pharmacists can be involved in all aspects of care, from deciding treatment plans to educating patients, and in the growing role of oral treatments.

CAR T therapies are potentially revolutionizing the treatment of acute lymphoblastic leukemia (ALL).

As treatments improve and prostate cancer potentially becomes more of a chronic illness, pharmacists have a chance to shine.